secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001493152-24-002099
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health amends merger agreement with Superlatus; reduces consideration due to failed post-closing condition
--------------------------------------------------------------------------------

- Superlatus failed to meet post-closing condition to acquire Prestige Farms, leading to material breach.
- Amendment reduces merger consideration from 30,821,941 common shares to 1,712,328 common shares at $7.30/share.
- Superlatus surrenders 289,731 shares of Series B preferred stock back to the Company.
- Company releases Superlatus from breach claims; agrees to assist with future acquisitions within 3 months.
- Company Equity Value adjusted to $12,500,000 from previously higher value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315224002099/0001493152-24-002099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315224002099/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-002099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer